{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:55:19Z","timestamp":1794293719820,"version":"4.9.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dietary sodium restriction remains a guidelines-approved lifestyle recommendation for chronic heart failure (CHF) patients. However, its efficacy in clinical outcome improvement is dubious.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study evaluated whether dietary sodium restriction in CHF reduces clinical events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a systematic review of the following databases: Academic Search Ultimate, ERIC, Health Source Nursing\/Academic Edition, MEDLINE, Embase, Clinicaltrials.gov and Cochrane Library (trials) to find studies analysing the impact of sodium restriction in the adult CHF population. Both observational and interventional studies were included. Exclusion criteria included i.e.: sodium consumption assessment based only on natriuresis, in-hospital interventions or mixed interventions\u2014e.g. sodium and fluid restriction in one arm only. The review was conducted following PRISMA guidelines. Meta-analysis was performed for the endpoints reported in at least 3 papers. Analyses were conducted in Review Manager (RevMan) Version 5.4.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Initially, we screened 9175 articles. Backward snowballing revealed 1050 additional articles. Eventually, 9 papers were evaluated in the meta-analysis. All-cause mortality, HF-related hospitalizations and the composite of mortality and hospitalisation were reported in 8, 6 and 3 articles, respectively. Sodium restriction was associated with a higher risk of the composite endpoint (OR 4.12 [95% CI 1.23\u201313.82]) and did not significantly affect the all-cause mortality (OR 1.38 [95% CI 0.76\u20132.49]) or HF hospitalisation (OR 1.63 [95% CI 0.69\u20133.88]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a meta-analysis, sodium restriction in CHF patients worsened the prognosis in terms of a composite of mortality and hospitalizations and did not influence all-cause mortality and HF hospitalisation rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-023-02256-7","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T05:04:06Z","timestamp":1688101446000},"page":"1331-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Role of dietary sodium restriction in chronic heart failure: systematic review and meta-analysis"],"prefix":"10.1007","volume":"113","author":[{"given":"Szymon","family":"Urban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Fu\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8207-1723","authenticated-orcid":false,"given":"Miko\u0142aj","family":"B\u0142aziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Fu\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gracjan","family":"Iwanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksym","family":"Jura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Grzesiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Szyma\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Sta\u0144czykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuba","family":"Ptaszkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zymlinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Biegus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,30]]},"reference":[{"issue":"1","key":"2256_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/J.JCHF.2015.11.005","volume":"4","author":"CW Yancy","year":"2016","unstructured":"Yancy CW (2016) The Uncertainty of sodium restriction in heart failure: we can do better than this. JACC Heart Fail 4(1):39\u201341. https:\/\/doi.org\/10.1016\/J.JCHF.2015.11.005","journal-title":"JACC Heart Fail"},{"issue":"4","key":"2256_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCULATIONAHA.111.062430","volume":"126","author":"D Gupta","year":"2012","unstructured":"Gupta D, Georgiopoulou VV, Kalogeropoulos AP, Dunbar SB, Reilly CM, Sands JM, Fonarow GC, Jessup M, Gheorghiade M, Yancy C, Butler J (2012) Dietary sodium intake in heart failure. Circulation 126(4):479\u2013485. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.062430","journal-title":"Circulation"},{"issue":"10333","key":"2256_CR3","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0140-6736(22)00369-5","volume":"399","author":"JA Ezekowitz","year":"2022","unstructured":"Ezekowitz JA, Colin-Ramirez E, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Alemayehu W, McAlister FA, Arcand JA, Atherton J, Doughty R, Gupta M, Howlett J, Jaffer S, Lavoie A, Lund M, Marwick T, McKelvie R, Moe G, Pandey AS, Porepa L, Rajda M, Rheault H, Singh J, Toma M, Virani S, Zieroth S, Ezekowitz J, McAlister F, Pandey AS (2022) Reduction of dietary sodium to less than 100 Mmol in heart failure (SODIUM-HF): an international, open-label, randomized, controlled trial. Lancet 399(10333):1391\u20131400. https:\/\/doi.org\/10.1016\/S0140-6736(22)00369-5","journal-title":"Lancet"},{"key":"2256_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000313720","volume":"164","author":"E Chaney","year":"2010","unstructured":"Chaney E, Shaw A (2010) Pathophysiology of fluid retention in heart failure. Contrib Nephrol 164:46\u201353. https:\/\/doi.org\/10.1159\/000313720","journal-title":"Contrib Nephrol"},{"issue":"4","key":"2256_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/EURHEARTJ\/EHI603","volume":"27","author":"MHL van der Wal","year":"2006","unstructured":"van der Wal MHL, Jaarsma T, Moser DK, Veeger NJGM, van Gilst WH, van Veldhuisen DJ (2006) Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J 27(4):434\u2013440. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHI603","journal-title":"Eur Heart J"},{"issue":"36","key":"2256_CR6","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/EURHEARTJ\/EHAB368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Baumbach A, B\u00f6hm M, Burri H, \u010celutkiene J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gardner RS, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Piepoli MF, Price S, Rosano GMC, Ruschitzka F, Skibelund AK, de Boer RA, Schulze PC, Abdelhamid M, Aboyans V, Adamopoulos S, Anker SD, Arbelo E, Asteggiano R, Bauersachs J, Bayes-Genis A, Borger MA, Budts W, Cikes M, Damman K, Delgado V, Dendale P, Dilaveris P, Drexel H, Ezekowitz J, Falk V, Fauchier L, Filippatos G, Fraser A, Frey N, Gale CP, Gustafsson F, Harris J, Iung B, Janssens S, Jessup M, Konradi A, Kotecha D, Lambrinou E, Lancellotti P, Landmesser U, Leclercq C, Lewis BS, Leyva F, Linhart A, L\u00f8chen ML, Lund LH, Mancini D, Masip J, Milicic D, Mueller C, Nef H, Nielsen JC, Neubeck L, Noutsias M, Petersen SE, Petronio AS, Ponikowski P, Prescott E, Rakisheva A, Richter D, Schlyakhto E, Seferovic P, Senni M, Sitges M, Sousa-Uva M, Tocchetti CG, Touyz R, Tschoepe C, Waltenberger J, Krim M, Hayrapetyan H, Moertl D, Mustafayev I, Kurlianskaya A, Depauw M, Ku\u0161ljugi\u0107 Z, Gatzov P, Agathangelou P, Melenovsk\u00fd V, L\u00f8gstrup BB, Mostafa AM, Uuetoa T, Lassus J, Logeart D, Kipiani Z, Chrysohoou C, Sepp R, Ingimarsd\u00f3ttir IJ, O\u2019Neill J, Gotsman I, Iacoviello M, Bajraktari G, Lunegova O, Kamzola G, Massih TA, Benlamin H, \u017daliaduonyte D, Noppe S, Moore A, Vataman E, Boskovic A, Bennis A, Manintveld OC, Kostovska ES, Gulati G, Straburzy\u0144ska-Migaj E, Silva-Cardoso J, Rimba\u015f RC, Lopatin Y, Foscoli M, Stojkovic S, Goncalvesova E, Fras Z, Segovia J, Lindmark K, Maeder MT, Bsata W, Abid L, Altay H, Voronkov L, Davies C, Abdullaev T, Baigent CN, Antoniou S, Collet JP, Halvorsen S, Koskinas KC (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/EURHEARTJ\/EHAB368","journal-title":"Eur Heart J"},{"issue":"18","key":"2256_CR7","doi-asserted-by":"publisher","first-page":"E895","DOI":"10.1161\/CIR.0000000000001063","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145(18):E895\u2013E1032. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"2256_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.122.009879","author":"E Colin-Ramirez","year":"2023","unstructured":"Colin-Ramirez E, Sepehrvand N, Rathwell S, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Lanas F, Doughty R, McAlister FA, Ezekowitz JA (2023) Sodium restriction in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials. Circ Heart Fail. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.009879","journal-title":"Circ Heart Fail"},{"issue":"12","key":"2256_CR9","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1001\/JAMAINTERNMED.2018.4673","volume":"178","author":"KR Mahtani","year":"2018","unstructured":"Mahtani KR, Heneghan C, Onakpoya I, Tierney S, Aronson JK, Roberts N, Hobbs FDR, Nunan D (2018) Reduced salt intake for heart failure: a systematic review. JAMA Intern Med 178(12):1693\u20131700. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2018.4673","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2256_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.JCHF.2015.10.003","volume":"4","author":"SL Hummel","year":"2016","unstructured":"Hummel SL, Konerman MC (2016) Dietary sodium restriction in heart failure: a recommendation worth its salt? JACC Heart Fail 4(1):36\u201338. https:\/\/doi.org\/10.1016\/J.JCHF.2015.10.003","journal-title":"JACC Heart Fail"},{"issue":"3","key":"2256_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3945\/AJCN.110.004457","volume":"93","author":"JA Arcand","year":"2011","unstructured":"Arcand JA, Floras JS, Azevedo E, Mak S, Newton GE, Allard JP (2011) Evaluation of 2 methods for sodium intake assessment in cardiac patients with and without heart failure: the confounding effect of loop diuretics. Am J Clin Nutr 93(3):535\u2013541. https:\/\/doi.org\/10.3945\/AJCN.110.004457","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"2256_CR12","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/JOURNAL.PMED.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Altman D, Antes G, Atkins D, Barbour V, Barrowman N, Berlin JA, Clark J, Clarke M, Cook D, D\u2019Amico R, Deeks JJ, Devereaux PJ, Dickersin K, Egger M, Ernst E, G\u00f8tzsche PC, Grimshaw J, Guyatt G, Higgins J, Ioannidis JPA, Kleijnen J, Lang T, Magrini N, McNamee D, Moja L, Mulrow C, Napoli M, Oxman A, Pham B, Rennie D, Sampson M, Schulz KF, Shekelle PG, Tovey D, Tugwell P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1000097","journal-title":"PLoS Med"},{"key":"2256_CR13","unstructured":"Deeks JJ, Higgins JPT, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds). Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). Cochrane, 2022.\u00a0Available from https:\/\/www.training.cochrane.org\/handbook."},{"key":"2256_CR14","doi-asserted-by":"crossref","unstructured":"Fu R, Gartlehner G, Grant M, Shamliyan T, Sedrakyan A, Wilt TJ, Griffith L, Oremus M, Raina P, Ismaila A, Santaguida P, Lau J, Trikalinos TA (2010) Conducting quantitative synthesis when comparing medical interventions AHRQ and the effective health care program. Methods guide for effectiveness and comparative effectiveness reviews. Agency for Healthcare Research and Quality (US)","DOI":"10.1016\/j.jclinepi.2010.08.010"},{"key":"2256_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.D4002","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, Carpenter J, R\u00fccker G, Harbord RM, Schmid CH, Tetzlaff J, Deeks JJ, Peters J, Macaskill P, Schwarzer G, Duval S, Altman DG, Moher D, Higgins JPT (2011) Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.D4002","journal-title":"BMJ"},{"key":"2256_CR16","unstructured":"Chapter 25: Assessing risk of bias in a non-randomized study | Cochrane Training. https:\/\/training.cochrane.org\/handbook\/current\/chapter-25. Accessed 14 Feb 2023"},{"key":"2256_CR17","unstructured":"8 Assessing risk of bias in included studies. https:\/\/handbook-5-1.cochrane.org\/chapter_8\/8_assessing_risk_of_bias_in_included_studies.htm. Accessed 14 Feb 2023"},{"issue":"7454","key":"2256_CR18","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/BMJ.328.7454.1490","volume":"328","author":"AD Oxman","year":"2004","unstructured":"Oxman AD (2004) Grading quality of evidence and strength of recommendations. BMJ 328(7454):1490. https:\/\/doi.org\/10.1136\/BMJ.328.7454.1490","journal-title":"BMJ"},{"issue":"5","key":"2256_CR19","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/EJHF.1428","volume":"21","author":"J Biegus","year":"2019","unstructured":"Biegus J, Zymli\u0144ski R, Sokolski M, Todd J, Cotter G, Metra M, Jankowska EA, Banasiak W, Ponikowski P (2019) Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure. Eur J Heart Fail 21(5):624\u2013633. https:\/\/doi.org\/10.1002\/EJHF.1428","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2256_CR20","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/J.CARDFAIL.2022.05.015","volume":"28","author":"JJ Herrmann","year":"2022","unstructured":"Herrmann JJ, Beckers-Wesche F, Baltussen LEHJM, Verdijk MHI, Bellersen L, Brunner-la Rocca HP, Jaarsma T, Pisters R, Sanders-van Wijk S, Rodwell L, van Royen N, Gommans DHF, van Kimmenade RRJ (2022) Fluid REStriction in heart failure vs liberal fluid UPtake: rationale and design of the randomized FRESH-UP study. J Card Fail 28(10):1522\u20131530. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2022.05.015","journal-title":"J Card Fail"},{"issue":"2","key":"2256_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1536\/IHJ.14-288","volume":"56","author":"Y Li","year":"2015","unstructured":"Li Y, Fu B, Qian X (2015) Liberal versus restricted fluid administration in heart failure patients a systematic review and meta-analysis of randomized trials. Int Heart J 56(2):192\u2013195. https:\/\/doi.org\/10.1536\/IHJ.14-288","journal-title":"Int Heart J"},{"issue":"5","key":"2256_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jchf.2019.02.011","volume":"7","author":"P Martens","year":"2019","unstructured":"Martens P, Dupont M, Verbrugge FH, Damman K, Degryse N, Nijst P, Reynders C, Penders J, Tang WHW, Testani J, Mullens W (2019) Urinary sodium profiling in chronic heart failure to detect development of acute decompensated heart failure. JACC Heart Fail 7(5):404\u2013414. https:\/\/doi.org\/10.1016\/j.jchf.2019.02.011","journal-title":"JACC Heart Fail"},{"issue":"4","key":"2256_CR23","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/ehf2.13372","volume":"8","author":"J Biegus","year":"2021","unstructured":"Biegus J, Zymli\u0144ski R, Fudim M, Testani J, Sokolski M, Marciniak D, Ponikowska B, Guzik M, Garus M, Urban S, Ponikowski P (2021) Spot urine sodium in acute heart failure: differences in prognostic value on admission and discharge. ESC Heart Fail 8(4):2597\u20132602. https:\/\/doi.org\/10.1002\/ehf2.13372","journal-title":"ESC Heart Fail"},{"issue":"11","key":"2256_CR24","doi-asserted-by":"publisher","first-page":"E006977","DOI":"10.1161\/CIRCHEARTFAILURE.120.006977","volume":"13","author":"O Unlu","year":"2020","unstructured":"Unlu O, Levitan EB, Reshetnyak E, Kneifati-Hayek J, Diaz I, Archambault A, Chen L, Hanlon JT, Maurer MS, Safford MM, Lachs MS, Goyal P (2020) Polypharmacy in older adults hospitalized for heart failure. Circ Heart Fail 13(11):E006977. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.006977","journal-title":"Circ Heart Fail"},{"issue":"5","key":"2256_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/ejhf.2053","volume":"23","author":"J Biegus","year":"2021","unstructured":"Biegus J, Zymli\u0144ski R, Testani J, Marciniak D, Zdanowicz A, Jankowska EA, Banasiak W, Ponikowski P (2021) Renal profiling based on estimated glomerular filtration rate and spot urine sodium identifies high-risk acute heart failure patients. Eur J Heart Fail 23(5):729\u2013739. https:\/\/doi.org\/10.1002\/ejhf.2053","journal-title":"Eur J Heart Fail"},{"key":"2256_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijcard.2021.10.149","volume":"345","author":"J Biegus","year":"2021","unstructured":"Biegus J, Nawrocka-Millward S, Zymli\u0144ski R, Fudim M, Testani J, Marciniak D, Rosiek-Biegus M, Ponikowska B, Guzik M, Garus M, Ponikowski P (2021) Distinct renin\/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure. Int J Cardiol 345:54\u201360. https:\/\/doi.org\/10.1016\/j.ijcard.2021.10.149","journal-title":"Int J Cardiol"},{"key":"2256_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.05.007","author":"ZL Cox","year":"2023","unstructured":"Cox ZL, Testani JM (2023) \u201cPouring Salt in the Wound\u201d of sodium restriction in acute heart failure. J Cardiac Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2023.05.007","journal-title":"J Cardiac Fail"},{"key":"2256_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2023.03.018","author":"RA Montgomery","year":"2023","unstructured":"Montgomery RA, Mauch J, Sankar P, Martyn T, Engelman T, Martens P, Faulkenberg K, Menon V, Estep JD, Tang WHW (2023) Oral sodium to preserve renal efficiency in acute heart failure: a randomized, placebo-controlled, double-blind study. J Cardiac Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.018","journal-title":"J Cardiac Fail"},{"issue":"11","key":"2256_CR29","doi-asserted-by":"publisher","first-page":"e1163","DOI":"10.1097\/CCM.0000000000005174","volume":"49","author":"C Liu","year":"2021","unstructured":"Liu C, Peng Z, Gao X, Gajic O, Dong Y, Prokop LJ, Murad MH, Kashani KB, Domecq JP (2021) Simultaneous use of hypertonic saline and IV furosemide for fluid overload: a systematic review and meta-analysis. Crit Care Med 49(11):e1163\u2013e1175. https:\/\/doi.org\/10.1097\/CCM.0000000000005174","journal-title":"Crit Care Med"},{"issue":"1","key":"2256_CR30","doi-asserted-by":"publisher","first-page":"e009879","DOI":"10.1161\/CIRCHEARTFAILURE.122.009879","volume":"16","author":"E Colin-Ramirez","year":"2023","unstructured":"Colin-Ramirez E, Sepehrvand N, Rathwell S, Ross H, Escobedo J, Macdonald P, Troughton R, Saldarriaga C, Lanas F, Doughty R, McAlister FA, Ezekowitz JA (2023) Sodium restriction in patients with heart failure: a systematic review and meta-analysis of randomized clinical trials. Circ Heart Fail 16(1):e009879. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.009879","journal-title":"Circ Heart Fail"},{"issue":"21","key":"2256_CR31","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","volume":"64","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O\u2019Connor CM (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64(21):2281\u20132293. https:\/\/doi.org\/10.1016\/j.jacc.2014.08.036","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2256_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cvr\/cvx149","volume":"114","author":"E Bertero","year":"2018","unstructured":"Bertero E, Prates Roma L, Ameri P, Maack C (2018) Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovasc Res 114(1):12\u201318. https:\/\/doi.org\/10.1093\/cvr\/cvx149","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2256_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","volume":"44","author":"J Biegus","year":"2023","unstructured":"Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE, Tromp J, Ferreira JP, Nassif ME, Psotka MA, Brueckmann M, Salsali A, Blatchford JP, Ponikowski P (2023) Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J 44(1):41\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehac530","journal-title":"Eur Heart J"},{"issue":"4","key":"2256_CR34","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/HYPERTENSIONAHA.119.11684","volume":"75","author":"CS Wilcox","year":"2020","unstructured":"Wilcox CS (2020) Antihypertensive and renal mechanisms of SGLT2 (sodium-glucose linked transporter 2) inhibitors. Hypertension (Dallas, Tex: 1979) 75(4):894\u2013901. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.11684","journal-title":"Hypertension (Dallas, Tex: 1979)"},{"issue":"1","key":"2256_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00392-022-02119-7","volume":"112","author":"J Kolwelter","year":"2023","unstructured":"Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, Bramlage P, N\u00f6h L, Schiffer M, Uder M, Achenbach S, Schmieder RE (2023) The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial. Clin Res Cardiol Offi J Ger Card Soc 112(1):134\u2013144. https:\/\/doi.org\/10.1007\/s00392-022-02119-7","journal-title":"Clin Res Cardiol Offi J Ger Card Soc"},{"key":"2256_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.D5928","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovi\u0107 J, Schulz KF, Weeks L, Sterne JAC (2011) The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. https:\/\/doi.org\/10.1136\/BMJ.D5928","journal-title":"BMJ"},{"key":"2256_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.I4919","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr\u00f3bjartsson A, Kirkham J, J\u00fcni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch\u00fcnemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. https:\/\/doi.org\/10.1136\/BMJ.I4919","journal-title":"BMJ"},{"key":"2256_CR38","doi-asserted-by":"publisher","DOI":"10.5603\/CJ.A2021.0098","author":"G Borrayo-Sanchez","year":"2021","unstructured":"Borrayo-Sanchez G, Coraz\u00f3n T, Ivey-Miranda JB, Almeida-Gutierrez E, Herrera-Saucedo R, Posada-Martinez EL, Chavez-Mendoza A, Mendoza-Zavala GH, Cigarroa-Lopez JA, Maga\u00f1a-Serrano JA, Rivera-Lea\u00f1os R, Trevi\u00f1o-Mejia A, Revilla-Monsalve C, Flores-Umanzor EJ, Espinola-Zavaleta N, Orea-Tejeda A, Gardu\u00f1o-Espinosa J, Saturno-Chiu G, Rao VS, Testani JM (2021) Sodium restriction in patients with chronic heart failure and reduced ejection fraction: a randomized controlled trial. Cardiol J. https:\/\/doi.org\/10.5603\/CJ.A2021.0098","journal-title":"Cardiol J"},{"issue":"2","key":"2256_CR39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.4274\/HASEKI.GALENOS.2021.6963","volume":"59","author":"B Senturk","year":"2021","unstructured":"Senturk B, Kaya H, Celik A, Bekar L, Gungor H, Zoghi M, Ural D, Cavusoglu Y, Temizhan A, Yilmaz MB (2021) Noncompliance with dietary salt restriction and outcomes in chronic heart failure: a propensity score matching analysis from treat-Hf registry. Haseki Tip Bulteni 59(2):114\u2013121. https:\/\/doi.org\/10.4274\/HASEKI.GALENOS.2021.6963","journal-title":"Haseki Tip Bulteni"},{"issue":"8","key":"2256_CR40","doi-asserted-by":"publisher","first-page":"e004886","DOI":"10.1161\/CIRCHEARTFAILURE.117.004886","volume":"11","author":"SL Hummel","year":"2018","unstructured":"Hummel SL, Karmally W, Gillespie BW, Helmke S, Teruya S, Wells J, Trumble E, Jimenez O, Marolt C, Wessler JD, Cornellier ML, Maurer MS (2018) Home-delivered meals postdischarge from heart failure hospitalization. Circ Heart Fail 11(8):e004886. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004886","journal-title":"Circ Heart Fail"},{"issue":"1","key":"2256_CR41","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/J.JCHF.2015.08.007","volume":"4","author":"R Doukky","year":"2016","unstructured":"Doukky R, Avery E, Mangla A, Collado FM, Ibrahim Z, Poulin MF, Richardson DJ, Powell LH (2016) Impact of dietary sodium restriction on heart failure outcomes. JACC Heart Fail 4(1):24\u201335. https:\/\/doi.org\/10.1016\/J.JCHF.2015.08.007","journal-title":"JACC Heart Fail"},{"issue":"6","key":"2256_CR42","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1177\/1474515113517574","volume":"13","author":"EK Song","year":"2014","unstructured":"Song EK, Moser DK, Dunbar SB, Pressler SJ, Lennie TA (2014) Dietary sodium restriction below 2 g per day predicted shorter event-free survival in patients with mild heart failure. Eur J Cardiovasc Nurs 13(6):541\u2013548. https:\/\/doi.org\/10.1177\/1474515113517574","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"2","key":"2256_CR43","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3945\/AJCN.110.000174","volume":"93","author":"JA Arcand","year":"2011","unstructured":"Arcand JA, Ivanov J, Sasson A, Floras V, Al-Hesayen A, Azevedo ER, Mak S, Allard JP, Newton GE (2011) A high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Am J Clin Nutr 93(2):332\u2013337. https:\/\/doi.org\/10.3945\/AJCN.110.000174","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"2256_CR44","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/J.CARDFAIL.2009.06.002","volume":"15","author":"G Parrinello","year":"2009","unstructured":"Parrinello G, di Pasquale P, Licata G, Torres D, Giammanco M, Fasullo S, Mezzero M, Paterna S (2009) Long-term effects of dietary sodium intake on cytokines and neurohormonal activation in patients with recently compensated congestive heart failure. J Card Fail 15(10):864\u2013873. https:\/\/doi.org\/10.1016\/J.CARDFAIL.2009.06.002","journal-title":"J Card Fail"},{"issue":"3","key":"2256_CR45","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1042\/CS20070193","volume":"114","author":"S Paterna","year":"2008","unstructured":"Paterna S, Gaspare P, Fasullo S, Sarullo FM, di Pasquale P (2008) Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond) 114(3):221\u2013230. https:\/\/doi.org\/10.1042\/CS20070193","journal-title":"Clin Sci (Lond)"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02256-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02256-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02256-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T11:04:29Z","timestamp":1725361469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02256-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,30]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["2256"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02256-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.03.17.23287429","asserted-by":"object"}]},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,30]]},"assertion":[{"value":"30 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prof. Piotr Ponikowski\u00a0has received personal fees for consultancy and Speakers Bureau from AstraZeneca, Boehringer Ingelheim, Vifor Pharma, Servier, Bayer, Bristol Myers Squibb, Respocardia, Berlin-Chemie, Cibiem, Novartis, and Renal Guard; other support for participation in clinical trials from Boehringer Ingelheim, Amgen, Vifor Pharma, Bayer, Bristol Myers Squibb, Cibiem, Novartis, and RenalGuard; and research grants to his institution from Vifor Pharma. All other authors have no conflicts of interest to declare that are relevant to the content of this article.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}